« Charles River Buys WuXi |
| Masses of Data, In Every Sample »
April 26, 2010
Last year I wrote about the hideous structure of maitotoxin, with a note about how various groups were kicking around synthetic approaches to it. Now K. C. Nicolaou has a paper out in JACS on the synthesis of a portion of the molecule, which includes the line: ". . .as a prelude to a possible synthesis of large domains of this molecule for biological investigations. . .". Yeah, sure. Betting will now commence on whether or not he'll be able to resist going for the whole thing. As to whether or not that's a good idea, well. . .my views on the subject have already been aired pretty thoroughly.
+ TrackBacks (0) | Category: Chemical News
POST A COMMENT
- RELATED ENTRIES
- Google's Nanoparticle Diagnostic Ideas
- Aileron Heads Toward the Clinic
- Viehbacher Out at Sanofi
- Rumblings About AstraZeneca and Antibiotics
- Amgen Cuts Harder
- An Open-Source Cancer Pitch, Deconstructed
- Sanofi - Trouble At the Top?
- Sarepta's Duchenne Therapy Is A Lot Further Away